Measuring ovarian cancer care: Why are we still failing?

Gynecologic Oncology

Volumn 136, Issue 1, 2015, Pages 1-2

  Goff, Barbara A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CYTOREDUCTIVE SURGERY; EDITORIAL; HUMAN; MEDICAL CARE; OVARY CANCER; PATIENT CARE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SURVIVAL RATE; UROGENITAL SYSTEM PARAMETERS; FEMALE; MORTALITY; OVARIAN NEOPLASMS;

FEMALE; HUMANS; OVARIAN NEOPLASMS;

EID: 84925228246     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.12.008     Document Type: Editorial

References (8)

1. Cliby W, Powell M, Noor AH, Miller JP Cheng L, Roland P, Mutch D, et al. Ovarian cancer care in the United Sates: Contemporary patterns of care associated with improved survival. Gynecol Oncol 2015.
2. Siegel R, Jiemin M, Zou Z, Jemal A. Cancer Statistics 2014. CA Cancer J Clin 2014;64: 9-29.
3. Chang SJ, Hodeib M, Chang J, Bristow RE. Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis. Gynecol Oncol 2013;130:493-8.
4. Landrum LM, Java J, Mathews CA, Lanneau Jr GS, Copeland LJ, Armstrong DK, et al. Prognostic factors for stage III epithelial cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study. Gynecol Oncol 2013;130(1):12-8.
5. Katsumata N, Yasuda M, Isonishi S, Takahashi F, Michimae H, et al. Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial, fallopian tube, or primary peritoneal cancer (JGOG 3016): A randomized, controlled, open-label trial. Lancet Oncol 2013; 14(10):1020-6.
6. Thrall MM, Gray HJ, Symons RG, Weiss NS, Flum DR, Goff BA. Trends in treatment of advanced epithelial ovarian cancer in the Medicare population. Gynecol Oncol 2011; 122:100-6.
7. Bristow RE, Change J, Ziogas A, Anton-Culver H. Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol 2013;121(6): 1226-34.
8. Woo YL, Kyrgiou M, Bryant M, Everett T, Dickinson HO. Centralisation of services for gynaecologic cancers: A Cochrane systematic review. Gynecol Oncol 2012;126(2): 286-90.